Scientists are developing artificial blood for use in emergencies

It could aid in global blood shortages

Photo collage of a red-tinted blood bag hanging from a drip stand, a hand holding a blood vial, another hand holding a droplet-shaped piece of paper with a puzzle piece drawn on it, and a vintage post stamp that says "giving blood saves lives". In the background, there is a fragment of a hospital building with an emergency sign on it, and a cloud of red liquid dispersing in water.
Artificial blood can be a shelf-stable alternative to blood donation
(Image credit: Illustration by Julia Wytrazek / Getty Images)

Around the world, researchers are on a quest to create artificial blood. This blood would be universal and capable of lasting years, allowing it to be used in medical emergencies or remote locations. However, formulating an alternative to the crucial liquid of life is no easy feat.

Build-a-blood

In Japan, clinical trials are underway to "assess artificial blood, usable for all blood types and storable for up to two years, as a potential solution to critical shortages in blood supplies for emergency and chronic health care worldwide," said Newsweek. The artificial blood "contains hemoglobin molecules from expired donor blood, which are encapsulated in protective lipid shells to create artificial red blood cells," said News Nation. "The new mixture is capable of carrying oxygen throughout the body."

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up

In Maryland, scientists have concocted similar artificial blood that can be freeze-dried to last for years. "It's designed so that at the moment it's needed, a medic can mix it with water and within a minute you have blood," said Allan Doctor, a scientist at the University of Maryland, to NPR. "The point is so you can give a transfusion at the scene of an accident." Real blood only lasts about 42 days. The artificial blood has already shown promise in rabbits, and the researchers are hopeful for human trials.

In the red

Currently, "approximately 118.5 million blood donations are collected worldwide, with 40% gathered in high-income countries, which comprise only 16% of the global population," said Al Jazeera. Experts estimate that "2,000 units of blood per 100,000 people are needed to meet global medical demands," but "severe shortages persist, especially in sub-Saharan Africa, South Asia and Oceania."

Access to artificial blood could save lives. More than 150,000 civilians in the U.S., and more than five million civilians globally, die each year from accidental injuries, many of which are attributed to blood loss. Also, a "large portion of the global population has limited access to blood transfusion treatment, said Newsweek. "Universal artificial blood could reduce preventable deaths in injury, surgery and childbirth," especially in low-income nations. In addition, the "No. 1 cause of preventable death on the battlefield is hemorrhage," said Col. Jeremy Pamplin, the project manager at the Defense Advanced Research Projects Agency that is funding research into artificial blood, to NPR. "That's a real problem for the military and for the civilian world."

Artificial blood could fill a crucial gap in the shortage. "But because this field has been so challenging, the proof will be in the clinical trials," said Tim Estep, a scientist at Chart Biotech Consulting who consults with companies developing artificial blood, to NPR. "While I'm overall optimistic, placing a bet on any one technology right now is difficult."

Devika Rao, The Week US

 Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.